Trastuzumab Deruxtecan in Advanced Breast Cancer
- Status
- RECRUITING
- Phase
- N/A
Clinical Trials Related to Advanced Breast Cancer
Related studies linked through entity extraction aliases.
Iparomlimab and Tuvonralimab (QL1706) in Patients With HR-positive, HER2-negative Advanced Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Continuous or Intermittent Pyrotinib for HER2-positive Advanced Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Emulation of the PALOMA-2 Trial
- Status
- COMPLETED
- Phase
- N/A
A Phase Ib/II Study of QLC1401 Combined With CDK4/6 or mTOR Inhibitors in ER+/HER2- Advanced Breast Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
A Study of MHB036C Combined With MHB039A in Patients With Advanced Breast Cancer or Other Advanced Malignant Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE2
SHR2554 Combined With Endocrine Therapy in Advanced Breast Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Study of DM5167 in Patients With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
A Study Comparing the Efficacy and Safety of HB1801 With Taxotere® in Advanced Breast Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Study of SHR-A2102 Combined Other Antitumor Drugs in Advanced Breast Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Efficacy and Safety of Trastuzumab Rezetecan Followed by CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2-Low/Ultra-Low Advanced Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE3
A Study of Sirolimus (Albumin-Bound) in Combination With Palbociclib and Fulvestrant for the Treatment of Advanced Breast Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Impact of BMI on CDK4/6 Inhibitors Efficacy and Safety in Advanced Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Whole Body MRI in Oncology
- Status
- RECRUITING
- Phase
- N/A
A Prospective, Multicenter, Observational Cohort Study Assessing the Efficacy and Safety of Radiotherapy-sensitized Immunotherapy in Advanced Breast Cancer
- Status
- RECRUITING
- Phase
- N/A
HS-10502 Combination Treatment in Patients With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Chidamide Combined With Angiogenesis Inhibitors and Fulvestrant for Advanced HR-positive, HER2-negative Breast Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2